First description of somatic mosaicism in MYH9 disorders

Shinji Kunishima1, Tadashi Matsushita, Takao Yoshihara

  • 1Department of Haemostasis and Thrombosis, Clinical Research Centre, National Hospital Organization Nagoya Medical Centre, Nagoya, Japan. kunishis@nnh.hosp.go.jp

Insights

MYH9 disorders, typically inherited, can arise from somatic mosaicism. This case reveals a father with MYH9 mutations in some cells, explaining his son's condition.

Area of Science:

  • Genetics
  • Hematology

Background:

  • MYH9 disorders are inherited conditions causing giant platelets and thrombocytopenia due to mutations in the MYH9 gene.
  • These disorders usually follow autosomal dominant inheritance, but sporadic cases also occur.

Observation:

  • A patient presented with features of MYH9 disorder, including giant platelets and neutrophil inclusions, but had normal platelet counts.
  • Genetic analysis revealed the MYH9 mutation was present in only a fraction of his blood cells, indicating somatic mosaicism.

Findings:

  • This study reports the first case of an MYH9 disorder caused by somatic mosaicism in a father whose son had May-Hegglin anomaly.
  • Quantitative analysis confirmed low-level mosaicism for the MYH9 mutation in the father's peripheral blood leukocytes, buccal mucosa, and hair bulb cells.

Implications:

  • Somatic mosaicism in MYH9 disorders, previously undocumented, may explain some de novo mutations.
  • This finding expands the understanding of MYH9 disorder etiology and inheritance patterns.

Related Concept Videos

Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by a...
Meiosis I03:09

Meiosis I

Meiosis is the division of a diploid cell into haploid cells forming sperm and eggs in animals through differentiation. Meiosis I is the first stage of meiosis, where the genetic recombination of homologous chromosomes and the reduction of the ploidy level by half occurs.
Prophase I is the most extended and complex step of meiosis I characterized by synapsis, chromosome pairing, and recombination of the homologous chromosomes. This process is facilitated by a proteinaceous structure called the...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...